Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Computational studies reveal Fluorine based quinolines to be potent inhibitors for proteins involved in SARS-CoV-2 assembly

Journal Article · · Journal of Fluorine Chemistry
 [1];  [2];  [2];  [1]
  1. National Institute of Technology Warangal (NITW), Telangana (India)
  2. Sinhgad Technical Education Society, Maharashtra (India)
World is witnessing one of the worst pandemics of this century caused by SARS-CoV-2 virus which has affected millions of individuals. Despite rapid efforts to develop vaccines and drugs for COVID-19, the disease is still not under control. Chloroquine (CQ) and Hydroxychloroquine (HCQ) are two very promising inhibitors which have shown positive effect in combating the disease in preliminary experimental studies, but their use was reduced due to severe side-effects. Here, we performed a theoretical investigation of the same by studying the binding of the molecules with SARS-COV-2 Spike protein, the complex formed by Spike and ACE2 human receptor and a human serine protease TMPRSS2 which aids in cleavage of the Spike protein to initiate the viral activation in the body. Both the molecules had shown very good docking energies in the range of -6kcal/mol. Subsequently, we did a high throughput screening for other potential quinoline candidates which could be used as inhibitors. From the large pool of ligand candidates, we shortlisted the top three ligands (binding energy -8kcal/mol). We tested the stability of the docked complexes by running Molecular Dynamics (MD) simulations where we observed the stability of the quinoline analogues with the Spike-ACE2 and TMPRSS2 nevertheless the quinolines were not stable with the Spike protein alone. Thus, although the inhibitors bond very well with the protein molecules their intrinsic binding affinity depends on the protein dynamics. Moreover, the quinolines were stable when bound to electronegative pockets of Spike-ACE2 or TMPRSS2 but not with Viral Spike protein. We also observed that a Fluoride based compound: 3-[3-(Trifluoromethyl)phenyl]quinoline helps the inhibitor to bind with both Spike-ACE2 and TMPRSS2 with equal probability. The molecular details presented in this study would be very useful for developing quinoline based drugs for COVID-19 treatment.
Research Organization:
Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States). National Energy Research Scientific Computing Center (NERSC)
Sponsoring Organization:
USDOE Office of Science (SC), Basic Energy Sciences (BES). Scientific User Facilities (SUF)
Grant/Contract Number:
AC02-05CH11231
OSTI ID:
1981666
Journal Information:
Journal of Fluorine Chemistry, Journal Name: Journal of Fluorine Chemistry Journal Issue: C Vol. 250; ISSN 0022-1139
Publisher:
ElsevierCopyright Statement
Country of Publication:
United States
Language:
English

References (61)

A Fluorine Scan of Thrombin Inhibitors to Map the Fluorophilicity/Fluorophobicity of an Enzyme Active Site: Evidence for CF⋅⋅⋅CO Interactions journal June 2003
Fluorine in Medicinal Chemistry journal April 2004
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility journal December 2009
TMPRSS2: Potential Biomarker for COVID‐19 Outcomes journal May 2020
Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story journal January 2021
Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases journal August 2015
QTc Prolongation in COVID-19 Patients Using Chloroquine journal January 2021
Current Status of Multiple Drug Molecules, and Vaccines: An Update in SARS-CoV-2 Therapeutics journal July 2020
Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19 journal August 2020
Hydroxychloroquine in COVID-19: Potential Mechanism of Action Against SARS-CoV-2 journal August 2020
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods journal May 2020
Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach journal October 2020
Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19 journal January 2021
Targeted design of drug binding sites in the main protease of SARS-CoV-2 reveals potential signatures of adaptation journal May 2021
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor journal April 2020
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein journal April 2020
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2 journal May 2020
A molecular docking model of SARS-CoV S1 protein in complex with its receptor, human ACE2 journal June 2005
Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries journal May 2020
COVID-19 and hydroxychloroquine: Is the wonder drug failing? journal August 2020
Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting journal October 2020
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial journal July 2020
A pharmacological perspective of chloroquine in SARS-CoV-2 infection: An old drug for the fight against a new coronavirus? journal September 2020
Chloroquine and hydroxychloroquine in coronavirus disease 2019 (COVID-19). Facts, fiction and the hype: a critical appraisal journal September 2020
A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells journal May 2020
Psychopharmacology of COVID-19 journal September 2020
COVID-19 outbreak: Migration, effects on society, global environment and prevention journal August 2020
Is the Rigidity of SARS-CoV-2 Spike Receptor-Binding Motif the Hallmark for Its Enhanced Infectivity? Insights from All-Atom Simulations journal May 2020
Enamine N-Oxides: Synthesis and Application to Hypoxia-Responsive Prodrugs and Imaging Agents journal March 2021
Contribution of Organofluorine Compounds to Pharmaceuticals journal April 2020
An Enzymatic TMPRSS2 Assay for Assessment of Clinical Candidates and Discovery of Inhibitors as Potential Treatment of COVID-19 journal September 2020
Can SARS-CoV-2 Accumulate Mutations in the S-Protein to Increase Pathogenicity? journal September 2020
UFF, a full periodic table force field for molecular mechanics and molecular dynamics simulations journal December 1992
The Discovery of Ezetimibe:  A View from Outside the Receptor journal January 2004
Structure and Dynamics of the TIP3P, SPC, and SPC/E Water Models at 298 K journal November 2001
CHARMM36m: an improved force field for folded and intrinsically disordered proteins journal November 2016
Identification of the first synthetic inhibitors of the type II transmembrane serine protease TMPRSS2 suitable for inhibition of influenza virus activation journal May 2013
Drug Evaluation during the Covid-19 Pandemic journal June 2020
COVID-19: a novel zoonotic disease caused by a coronavirus from China: what we know and what we don't journal January 2020
Cell entry mechanisms of SARS-CoV-2 journal May 2020
Rheumotologitsts’ view on the use of hydroxychloroquine to treat COVID-19 journal January 2020
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) journal March 2020
The Protein Data Bank journal January 2000
PubChem 2019 update: improved access to chemical data journal October 2018
Crystal structure of the catalytic domain of DESC1, a new member of the type II transmembrane serine proteinase family journal March 2007
Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor journal September 2005
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 journal March 2020
A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV journal April 2020
Gene of the month: TMPRSS2 (transmembrane serine protease 2) journal September 2020
Structure, Function, and Evolution of Coronavirus Spike Proteins journal September 2016
Primum non nocere – Are chloroquine and hydroxychloroquine safe prophylactic/treatment options for SARS-CoV-2 (covid-19)? journal July 2020
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread journal August 2005
SARS-CoV-2 variants reveal features critical for replication in primary human cells journal March 2021
The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer journal September 2020
Risk of using hydroxychloroquine as a treatment of COVID-19 journal August 2020
COVID-19: Targeting Proteases in Viral Invasion and Host Immune Response journal October 2020
Computational Analysis of Targeting SARS-CoV-2, Viral Entry Proteins ACE2 and TMPRSS2, and Interferon Genes by Host MicroRNAs journal November 2020
Viral Pandemics of the Last Four Decades: Pathophysiology, Health Impacts and Perspectives journal December 2020
Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism journal January 2021
Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein journal June 2012
Comparative molecular docking analysis of the SARS CoV-2 Spike glycoprotein with the human ACE-2 receptors and thrombin journal July 2020